Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Chi Lin

Showing results (111-120 of 231) with videos related to

Pageof 24
Sort By:
Journal of Bioscience and Bioengineering|June 15, 2013
Production of D-hydantoinase via surface display and self-cleavage systemChia-Chi Lin, Tzu-Tsen Liu, Shu-Chen Kan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 25, 2009
Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancerChia-Chi Lin, Chih-Hung Hsu, Jason C Cheng, et al.
Mucosal Immunology|October 7, 2023
Acrylamide, an air pollutant, enhances allergen-induced eosinophilic lung inflammation via group 2 innate lymphoid cellsHsiang-Han Su, Chih-Mei Cheng, Yung-Ning Yang, et al.
Clinical Pharmacology and Therapeutics|May 17, 2021
Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab DeruxtecanOphelia Yin, Hiroji Iwata, Chia-Chi Lin, et al.
Investigational New Drugs|June 19, 2015
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 doseKarthik Venkatakrishnan, Tae Min Kim, Chia-Chi Lin, et al.
Cancer Science|July 29, 2016
Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumorsHironobu Minami, Yuichi Ando, Brigette Buig Yue Ma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
First-Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer: Final Overall Survival Results from a Randomized Phase 3 StudyJames Chih-Hsin Yang, Vichien Srimuninnimit, Myung-Ju Ahn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal CarcinomatosisBin-Chi Liao, Jih-Hsiang Lee, Chia-Chi Lin, et al.
Cancer Medicine|March 29, 2022
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimensWei-Li Ma, Chia-Chi Lin, Feng-Ming Hsu, et al.
Clinical Lung Cancer|February 26, 2018
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer PatientsTing-Hui Wu, Emily Han-Chung Hsiue, Jih-Hsiang Lee, et al.
Pageof 24

Showing results (111-120 of 231) with videos related to

Sort By:
Pageof 24
Journal of Bioscience and Bioengineering|June 15, 2013
Production of D-hydantoinase via surface display and self-cleavage systemChia-Chi Lin, Tzu-Tsen Liu, Shu-Chen Kan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 25, 2009
Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancerChia-Chi Lin, Chih-Hung Hsu, Jason C Cheng, et al.
Mucosal Immunology|October 7, 2023
Acrylamide, an air pollutant, enhances allergen-induced eosinophilic lung inflammation via group 2 innate lymphoid cellsHsiang-Han Su, Chih-Mei Cheng, Yung-Ning Yang, et al.
Clinical Pharmacology and Therapeutics|May 17, 2021
Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab DeruxtecanOphelia Yin, Hiroji Iwata, Chia-Chi Lin, et al.
Investigational New Drugs|June 19, 2015
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 doseKarthik Venkatakrishnan, Tae Min Kim, Chia-Chi Lin, et al.
Cancer Science|July 29, 2016
Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumorsHironobu Minami, Yuichi Ando, Brigette Buig Yue Ma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
First-Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer: Final Overall Survival Results from a Randomized Phase 3 StudyJames Chih-Hsin Yang, Vichien Srimuninnimit, Myung-Ju Ahn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal CarcinomatosisBin-Chi Liao, Jih-Hsiang Lee, Chia-Chi Lin, et al.
Cancer Medicine|March 29, 2022
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimensWei-Li Ma, Chia-Chi Lin, Feng-Ming Hsu, et al.
Clinical Lung Cancer|February 26, 2018
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer PatientsTing-Hui Wu, Emily Han-Chung Hsiue, Jih-Hsiang Lee, et al.
Pageof 24